DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Mercer - 2 Gary Kushner - 2 Gallagher - 2 Aon - 1 there's - 1 Willis Towers Watson - 1 WTW - 1 Beth Umland - 1
Top related locs:
U.S North America Mercer's
Top related orgs:
Finance - 2 Security - 2 Kushner & Company - 2 Workers - 1 North - 1 IRS - 1

Search resuls for: "Gary Kushner"


2 mentions found


☆ Health-care costs hit a post-pandemic high. These moves during open enrollment can help
  + stars: | 2024-10-14 | by ( Jessica Dickler | ) www.cnbc.com   time to read: +7 min
Because of higher costs, employers are considering new ways to adjust their plan offerings, WTW found. Currently, employers subsidize about 81% of health-care plan costs, on average, while employees pay the remainder, according to professional services firm Aon. For workers, health-care expenses are already high: Family premiums for employer-sponsored health insurance rose 7% this year to an average of $25,572, KFF's 2024 benchmark employer health survey found. Health savings accountsAlong with a high-deductible health insurance plan, more than 50% of employers also offer a health savings account, or HSA, which can help with additional health-care costs. This is called supplemental life insurance, or voluntary life insurance, and it's optional coverage that you can add to your employer's basic group policy.
Persons: Aon, there's, Willis Towers Watson, WTW, Mercer, Beth Umland, Tim Stawicki, Regina Ihrke, Gary Kushner, WTW's Ihrke, Ihrke, Gallagher, Tom Kelly Organizations: Finance, Security, Workers, North, Kushner & Company, IRS Locations: U.S, North America
☆ Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
  + stars: | 2024-10-11 | by ( Jessica Dickler | ) www.cnbc.com   time to read: +2 min
About 165 million Americans rely on employer-sponsored health insurance and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Wegovy and Novo Nordisk's diabetes drug Ozempic. One in three employees are looking for more resources to combat obesity, according to a recent report by consulting firm Gallagher. Glucagon-like peptide-1 treatments such as Wegovy and Ozempic, which mimic hormones produced in the gut to suppress a person's appetite, are considered game changers on this front. Already, prescription drug costs jumped 8.6% last year, due in part to a surge in the use of GLP-1 drugs, according to a recent report by Mercer. "It becomes a lifelong drug," said Gary Kushner, chair and president of Kushner & Company, a benefits design and management company.
Persons: Gallagher, Trilliant, Mercer, Sunit Patel, actuary, Gary Kushner Organizations: Finance, Security, Kushner & Company Locations: U.S, Mercer's
0 next >>
Total: 2